{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:33:47Z","timestamp":1763746427613,"version":"3.37.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1124\/jpet.104.076653","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T04:45:17Z","timestamp":1111121117000},"page":"432-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Phenylpropanolamine Constricts Mouse and Human Blood Vessels by Preferentially Activating \u03b12-Adrenoceptors"],"prefix":"10.1016","volume":"313","author":[{"given":"Nicholas A.","family":"Flavahan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.076653_bib1","doi-asserted-by":"crossref","unstructured":"Alberts P, Bergstrom PA, and Fredrickson MG (1999) Characterisation of the functional alpha-adrenoceptor subtype in the isolated female pig urethra. Eur J Pharmacol 371: 31-38.","DOI":"10.1016\/S0014-2999(99)00182-X"},{"key":"10.1124\/jpet.104.076653_bib2","doi-asserted-by":"crossref","unstructured":"Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153: 586-600.","DOI":"10.1152\/ajplegacy.1948.153.3.586"},{"key":"10.1124\/jpet.104.076653_bib3","doi-asserted-by":"crossref","unstructured":"Andersson KE and Bende M (1984) Adrenoceptors in the control of human nasal mucosal blood flow. Ann Otol Rhinol Laryngol 93: 179-182.","DOI":"10.1177\/000348948409300216"},{"key":"10.1124\/jpet.104.076653_bib4","doi-asserted-by":"crossref","unstructured":"Armstrong JM, Lefevre-Borg F, Scatton B, and Cavero I (1982) Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat. J Pharmacol Exp Ther 223: 524-535.","DOI":"10.1016\/S0022-3565(25)33365-3"},{"key":"10.1124\/jpet.104.076653_bib5","doi-asserted-by":"crossref","unstructured":"Bognar IT and Enero MA (1988) Influence of a receptor reserve on the inhibition by calcium channel blockers of alpha adrenoceptor-mediated responses in rat isolated vascular tissues. J Pharmacol Exp Ther 245: 673-681.","DOI":"10.1016\/S0022-3565(25)22630-1"},{"key":"10.1124\/jpet.104.076653_bib6","doi-asserted-by":"crossref","unstructured":"Buckner SA, Milicic I, Daza AV, Meyer MD, Altenbach RJ, Williams M, Sullivan JP, and Brioni JD (2002) ABT-866, a novel alpha(1A)-adrenoceptor agonist with antagonist properties at the alpha(1B)- and alpha(1D)-adrenoceptor subtypes. Eur J Pharmacol 449: 159-165.","DOI":"10.1016\/S0014-2999(02)01976-3"},{"key":"10.1124\/jpet.104.076653_bib7","doi-asserted-by":"crossref","unstructured":"Chotani MA, Flavahan S, Mitra S, Daunt D, and Flavahan NA (2000) Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am J Physiol Heart Circ Physiol 278: H1075-H1083.","DOI":"10.1152\/ajpheart.2000.278.4.H1075"},{"key":"10.1124\/jpet.104.076653_bib8","doi-asserted-by":"crossref","unstructured":"Chotani MA, Mitra S, Su BY, Flavahan S, Eid AH, Clark KR, Montague CR, Paris H, Handy DE, and Flavahan NA (2004) Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286: H59-H67.","DOI":"10.1152\/ajpheart.00268.2003"},{"key":"10.1124\/jpet.104.076653_bib9","doi-asserted-by":"crossref","unstructured":"Daly CJ, Deighan C, McGee A, Mennie D, Ali Z, McBride M, and McGrath JC (2002) A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse. Physiol Genomics 9: 85-91.","DOI":"10.1152\/physiolgenomics.00065.2001"},{"key":"10.1124\/jpet.104.076653_bib10","doi-asserted-by":"crossref","unstructured":"Davies BT, Wellman PJ, and Morien A (1993) An assessment of the involvement of paraventricular hypothalamic alpha 2-adrenoceptors in phenylpropanolamine anorexia. Physiol Behav 54: 121-128.","DOI":"10.1016\/0031-9384(93)90053-I"},{"key":"10.1124\/jpet.104.076653_bib11","doi-asserted-by":"crossref","unstructured":"Dillon PF, Root-Bernstein RS, and Lieder CM (2004) Antioxidant-independent ascorbate enhancement of catecholamine-induced contractions of vascular smooth muscle. Am J Physiol Heart Circ Physiol 286: H2353-H2360.","DOI":"10.1152\/ajpheart.00968.2003"},{"key":"10.1124\/jpet.104.076653_bib12","doi-asserted-by":"crossref","unstructured":"Flavahan NA, Cooke JP, Shepherd JT, and Vanhoutte PM (1987) Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs. J Pharmacol Exp Ther 241: 361-365.","DOI":"10.1016\/S0022-5347(25)00268-X"},{"key":"10.1124\/jpet.104.076653_bib13","doi-asserted-by":"crossref","unstructured":"Flavahan NA and McGrath JC (1984) Are human vascular alpha-adrenoceptors atypical? J Cardiovasc Pharmacol 6: 208-210.","DOI":"10.1097\/00005344-198401000-00031"},{"key":"10.1124\/jpet.104.076653_bib14","doi-asserted-by":"crossref","unstructured":"Flavahan NA, Rimele TJ, Cooke JP, and Vanhoutte PM (1984) Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J Pharmacol Exp Ther 230: 699-705.","DOI":"10.1016\/S0022-3565(25)21728-1"},{"key":"10.1124\/jpet.104.076653_bib15","doi-asserted-by":"crossref","unstructured":"Flavahan NA, Shimokawa H, and Vanhoutte PM (1989) Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J Physiol (Lond) 408: 549-560.","DOI":"10.1113\/jphysiol.1989.sp017475"},{"key":"10.1124\/jpet.104.076653_bib16","doi-asserted-by":"crossref","unstructured":"Fox AW, Abel PW, and Minneman KP (1985) Activation of alpha 1-adrenoceptors increases [3H]inositol metabolism in rat vas deferens and caudal artery. Eur J Pharmacol 116: 145-152.","DOI":"10.1016\/0014-2999(85)90195-5"},{"key":"10.1124\/jpet.104.076653_bib17","doi-asserted-by":"crossref","unstructured":"Guimaraes S and Moura D (2001) Vascular adrenoceptors: an update. Pharmacol Rev 53: 319-356.","DOI":"10.1016\/S0031-6997(24)01495-9"},{"key":"10.1124\/jpet.104.076653_bib18","doi-asserted-by":"crossref","unstructured":"Hricik JG and Johnson DA (1996) Effects of dl-norephedrine and its enantiomers on norepinephrine uptake and release in isolated rat caudal artery. J Auton Nerv Syst 61: 186-190.","DOI":"10.1016\/S0165-1838(96)00084-7"},{"key":"10.1124\/jpet.104.076653_bib19","doi-asserted-by":"crossref","unstructured":"Hull KM, Sanderson WD, and Maher TJ (1993) Effect of phenylpropanolamine and related compounds on beta-adrenoceptor-induced activation of adenylyl cyclase. Life Sci 52: 1287-1294.","DOI":"10.1016\/S0024-3205(05)80018-9"},{"key":"10.1124\/jpet.104.076653_bib20","doi-asserted-by":"crossref","unstructured":"Kernan WN, Viscoli CM, Brass LM, Broderick JP, Brott T, Feldmann E, Morgenstern LB, Wilterdink JL, and Horwitz RI (2000) Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 343: 1826-1832.","DOI":"10.1056\/NEJM200012213432501"},{"key":"10.1124\/jpet.104.076653_bib21","doi-asserted-by":"crossref","unstructured":"Lacroix JS and Lundberg JM (1989) Sympathetic vascular control of the pig nasal mucosa: adrenoceptor mechanisms in blood flow and volume control. Br J Pharmacol 97: 1075-1084.","DOI":"10.1111\/j.1476-5381.1989.tb12564.x"},{"key":"10.1124\/jpet.104.076653_bib22","unstructured":"Lasanga L (1988) Phenylpropanolamine: A Review, John Wiley & Sons, Inc., New York."},{"key":"10.1124\/jpet.104.076653_bib23","doi-asserted-by":"crossref","unstructured":"McLeod RL, Erickson CH, Mingo GG, and Hey JA (2001) Intranasal application of the alpha2-adrenoceptor agonist BHT-920 produces decongestion in the cat. Am J Rhinol 15: 407-415.","DOI":"10.1177\/194589240101500610"},{"key":"10.1124\/jpet.104.076653_bib24","doi-asserted-by":"crossref","unstructured":"Minneman KP, Fox AW, and Abel PW (1983) Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens. Mol Pharmacol 23: 359-368.","DOI":"10.1016\/S0026-895X(25)14276-4"},{"key":"10.1124\/jpet.104.076653_bib25","doi-asserted-by":"crossref","unstructured":"Minneman KP and Johnson RD (1984) Characterization of alpha-1 adrenergic receptors linked to [3H]inositol metabolism in rat cerebral cortex. J Pharmacol Exp Ther 230: 317-323.","DOI":"10.1016\/S0022-3565(25)21469-0"},{"key":"10.1124\/jpet.104.076653_bib26","doi-asserted-by":"crossref","unstructured":"Moya-Huff FA and Maher TJ (1987) Adrenergic receptor subtype activation by (+)-, (-)- and (+\/-)-norephedrine in the pithed rat. J Pharm Pharmacol 39: 108-112.","DOI":"10.1111\/j.2042-7158.1987.tb06954.x"},{"key":"10.1124\/jpet.104.076653_bib27","doi-asserted-by":"crossref","unstructured":"Nase GP and Boegehold MA (1998) Postjunctional alpha 2-adrenoceptors are not present in proximal arterioles of rat intestine. Am J Physiol 274: H202-H208.","DOI":"10.1152\/ajpheart.1998.274.1.H202"},{"key":"10.1124\/jpet.104.076653_bib28","doi-asserted-by":"crossref","unstructured":"Nielsen H, Mortensen FV, and Mulvany MJ (1990) Differential distribution of postjunctional alpha 2 adrenoceptors in human omental small arteries. J Cardiovasc Pharmacol 16: 34-40.","DOI":"10.1097\/00005344-199007000-00006"},{"key":"10.1124\/jpet.104.076653_bib29","doi-asserted-by":"crossref","unstructured":"Nishimatsu H, Moriyama N, Hamada K, Ukai Y, Yamazaki S, Kameyama S, Konno N, Ishida Y, Ishii Y, Murayama T, et al. (1999) Contractile responses to alpha1-adrenoceptor agonists in isolated human male and female urethra. BJU Int 84: 515-520.","DOI":"10.1046\/j.1464-410x.1999.00218.x"},{"key":"10.1124\/jpet.104.076653_bib30","doi-asserted-by":"crossref","unstructured":"Saltzman MB, Dolan MM, and Doyne N (1983) Comparison of effects of two dosage regimens of phenylpropanolamine on blood pressure and plasma levels in normal subjects under steady-state conditions. Drug Intell Clin Pharm 17: 746-750.","DOI":"10.1177\/106002808301701012"},{"key":"10.1124\/jpet.104.076653_bib31","doi-asserted-by":"crossref","unstructured":"Sjoberg T, Steen S, Skarby T, Norgren L, and Andersson KE (1987) Postjunctional alpha-adrenoceptors in human superficial epigastric arteries and veins. Pharmacol Toxicol 60: 43-50.","DOI":"10.1111\/j.1600-0773.1987.tb01717.x"},{"key":"10.1124\/jpet.104.076653_bib32","doi-asserted-by":"crossref","unstructured":"Steen S, Sjoberg T, Skarby TV, Norgren L, and Andersson KE (1984a) Postjunctional alpha 1- and alpha 2-adrenoceptors mediating contraction in isolated human groin arteries and veins. Acta Physiol Scand 122: 323-329.","DOI":"10.1111\/j.1748-1716.1984.tb07516.x"},{"key":"10.1124\/jpet.104.076653_bib33","doi-asserted-by":"crossref","unstructured":"Steen S, Skarby TV, Norgren L, and Andersson KE (1984b) Pharmacological characterization of postjunctional alpha-adrenoceptors in isolated human omental arteries and veins. Acta Physiol Scand 120: 109-116.","DOI":"10.1111\/j.1748-1716.1984.tb07379.x"},{"key":"10.1124\/jpet.104.076653_bib34","unstructured":"Stevens MJ and Moulds RF (1981) Heterogeneity of post-junctional alpha-adrenoceptors in human vascular smooth muscle. Arch Int Pharmacodyn Ther 254: 43-57."},{"key":"10.1124\/jpet.104.076653_bib35","doi-asserted-by":"crossref","unstructured":"Stockley CS, Wing LM, Tonkin AL, and Miners JO (1994) Dispositional factors do not contribute to the enantiospecificity of the cardiovascular effects of phenylpropanolamine. Clin Pharmacol Ther 55: 35-43.","DOI":"10.1038\/clpt.1994.7"},{"key":"10.1124\/jpet.104.076653_bib36","doi-asserted-by":"crossref","unstructured":"Tornebrandt K, Nobin A, and Owman C (1985) Pharmacological characterization of alpha-adrenergic receptor subtypes mediating contraction in human mesenteric arteries and veins. Blood Vessels 22: 179-195.","DOI":"10.1159\/000158600"},{"key":"10.1124\/jpet.104.076653_bib37","doi-asserted-by":"crossref","unstructured":"Trendelenburg U, Muskus A, Fleming WW, and Gomez Alonso de la Sierra B (1962) Modification by reserpine of the action of sympathomimetic amines in spinal cats: a classification of sympathomimetic amines. J Pharmacol Exp Ther 138: 170-180.","DOI":"10.1016\/S0022-3565(25)26405-9"},{"key":"10.1124\/jpet.104.076653_bib38","doi-asserted-by":"crossref","unstructured":"von Euler US (1946) A specific sympathetic ergone in adrenergic nerve fibres (sympathin) and its relation to adrenaline and noradrenaline. Acta Physiol Scand 12: 73-97.","DOI":"10.1111\/j.1748-1716.1946.tb00368.x"},{"key":"10.1124\/jpet.104.076653_bib39","doi-asserted-by":"crossref","unstructured":"Wang M and Lung MA (2003) Adrenergic mechanisms in canine nasal venous systems. Br J Pharmacol 138: 145-155.","DOI":"10.1038\/sj.bjp.0705020"},{"key":"10.1124\/jpet.104.076653_bib40","doi-asserted-by":"crossref","unstructured":"Wellman PJ and Davies BT (1991) Suppression of feeding induced by phenylephrine microinjections within the paraventricular hypothalamus in rats. Appetite 17: 121-128.","DOI":"10.1016\/0195-6663(91)90067-3"},{"key":"10.1124\/jpet.104.076653_bib41","doi-asserted-by":"crossref","unstructured":"Wellman PJ and Davies BT (1992) Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the alpha 1-receptor antagonist prazosin. Pharmacol Biochem Behav 42: 97-100.","DOI":"10.1016\/0091-3057(92)90452-L"},{"key":"10.1124\/jpet.104.076653_bib42","doi-asserted-by":"crossref","unstructured":"Yamamoto Y and Koike K (2001) alpha(1)-Adrenoceptor subtypes in the mouse mesenteric artery and abdominal aorta. Br J Pharmacol 134: 1045-1054.","DOI":"10.1038\/sj.bjp.0704350"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524319329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524319329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.076653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:21:52Z","timestamp":1740000112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524319329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0022356524319329"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.076653","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylpropanolamine Constricts Mouse and Human Blood Vessels by Preferentially Activating \u03b12-Adrenoceptors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.076653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}